How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma

How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma

Uveal melanoma (UM), though a rare form of melanoma, is the most common intraocular tumor in adults. Conventional therapies of primary tumors lead to an excellent local control, but 50% of patients develop metastases, in most cases with lethal outcome. Somatic driver mutations that act on the MAP-ki...

Full description

Bibliographic Details
Main Authors: Mariarosaria Marseglia, Adriana Amaro, Nicola Solari, Rosaria Gangemi, Elena Croce, Enrica Teresa Tanda, Francesco Spagnolo, Gilberto Filaci, Ulrich Pfeffer, Michela Croce
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
uveal
immunotherapy
<i>BAP1</i>
tumor microenvironment
anti-PD-1
anti-CTLA-4
Online Access:https://www.mdpi.com/2072-6694/13/9/2043

Internet

https://www.mdpi.com/2072-6694/13/9/2043

Similar Items